<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap14" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>14</ChapterID>
            <ChapterNumber>14</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_14</ChapterDOI>
            <ChapterSequenceNumber>14</ChapterSequenceNumber>
            <ChapterTitle Language="En">MR Tracking of Stem Cells in Living Recipients</ChapterTitle>
            <ChapterFirstPage>197</ChapterFirstPage>
            <ChapterLastPage>215</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_14" CorrespondingAffiliationID="Aff1_14">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Eva</GivenName>
                  <FamilyName>Syková</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>sykova@biomed.cas.cz</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1_14">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Pavla</GivenName>
                  <FamilyName>Jendelová</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2_14" CorrespondingAffiliationID="Aff2_14">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Vít</GivenName>
                  <FamilyName>Herynek</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1_14">
                <OrgName>Institute of Experimental Medicine ASCR</OrgName>
                <OrgAddress>
                  <State>Víde ská</State>
                  <Postcode>1083</Postcode>
                  <Street>140 20 Prague 4</Street>
                  <Country>Czech Republic</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2_14">
                <OrgDivision>Department of Radiodiagnostic and Interventional Radiology</OrgDivision>
                <OrgName>Institute for Clinical and Experimental Medicine</OrgName>
                <OrgAddress>
                  <State>Prague</State>
                  <Country>Czech Republic</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_14" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>Noninvasive cellular imaging allows the real-time tracking of grafted cells as well as the monitoring of their migration. Several techniques for in vivo cellular imaging are available that permit the characterization of transplanted cells in a living organism, including magnetic resonance imaging (MRI), bioluminescence, positron emission tomography, and multiple photon microscopy. All of these methods, based on different principles, provide distinctive, usually complementary information. In this review, we will focus on cell tracking using MRI, since MRI is noninvasive, clinically transferable, and displays good resolution, ranging from 50μm in animal experiments up to 300μm using whole body clinical scanners. In addition to information about grafted cells, MRI provides information about the surrounding tissue (i.e., lesion size, edema, inflammation), which may negatively affect graft survival or the functional recovery of the tissue. Transplanted cells are labeled with MR contrast agents in vitro prior to transplantation in order to visualize them in the host tissue. The chapter will focus on the use of superparamagnetic iron oxide nanoparticles (SPIO), because they have strong effects on T2 relaxation yet do not affect cell viability, and will provide an overview of different modifications of SPIO and their use in MR tracking in living organisms.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words:</Heading>
              <Keyword>Contrast agets</Keyword>
              <Keyword>Nanoparticles</Keyword>
              <Keyword>Photochemical lesion</Keyword>
              <Keyword>Spinal cord injury</Keyword>
              <Keyword>Cell labeling</Keyword>
              <Keyword>Stroke</Keyword>
              <Keyword>Cellular imaging</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_14">
              <Heading>Introduction</Heading>
              <Para>Stem and progenitor cells are being explored in regenerative medicine for the cell therapy of disorders of the central nervous system (<CitationRef CitationID="CR1_14">1</CitationRef>–<CitationRef CitationID="CR9_14">9</CitationRef>). Crucial to the future success of cell transplantation in the clinical setting is the ability of transplanted cells to migrate from the site of transplantation to the lesioned area and to survive, differentiate, and replace lost nerve cells or produce growth factors and cytokines for a prolonged period of time in order to enhance the patient’s regenerative potential. Visualizing transplanted cells in vivo is essential for preclinical studies in rodents and potentially also in humans. The magnetic tracking of cells appears to be a valuable tool for such studies since MR imaging may serve to study cell migration to lesions, its time course, and how long the cells persist in the target region. Such information could help to elucidate the time window during which the transplantation of therapeutic cells may be clinically effective, the number of cells needed, and the optimal method of their administration. In addition to monitoring their migration, noninvasive cellular imaging allows the real-time tracking of grafted cells as well. Several techniques for in vivo cellular imaging are now available that allow the characterization of transplanted cells in a living organism, including magnetic resonance imaging (MRI), bioluminescence, positron emission tomography, and multiple photon microscopy. All of these imaging methods, based on different principles, provide distinctive, usually complementary information. In this chapter, we will focus on cell labeling for MRI, since MRI is noninvasive, clinically transferable and displays good resolution, ranging from 50μm in animal experiments up to 300μm when using whole body clinical scanners. In addition to information about grafted cells, MRI can provide information about the surrounding tissue (i.e., lesion size, edema, or inflammation), which may have a negative effect on graft survival or the functional recovery of the tissue.</Para>
              <Section2 ID="Sec2_14">
                <Heading>Cellular Imaging</Heading>
                <Para>Magnetic resonance imaging is used in clinical practice because it provides good soft tissue contrast, based on the differential distribution of hydrogen atoms (<Superscript>1</Superscript>H) in particular tissues. As hydrogen ions are present in water molecules, MRI images visualize the distribution of water in the extracellular and intracellular compartments of different types of tissues. MRI contrast agents alter the MR signal by changing the relaxivity of <Superscript>1</Superscript>H atoms in their vicinity. Changes in relaxivity are considered to affect either the spin–lattice relaxation (so-called T1 relaxation) or spin–spin relaxation (known as T2 relaxation). In an actual experimental system, T2 is reduced to T2* due to inhomogeneities in the magnetic field gradient. The relaxation rates R1 and R2 are the inverse of the relaxation times and express the effectiveness of the contrast agent. MR contrast agents contain metal ions that define their relaxation properties. Paramagnetic metals such as gadolinium, iron, and manganese mainly affect T1 relaxation, whereas superparamagnetic iron oxide (SPIO) nanoparticles predominantly reduce T2 and T2*. For cellular MRI, cells need to be labeled with an MR contrast agent in order to visualize them in the host tissue. Contrast agents suitable for cell labeling must not only have high relaxation rates, but they also must not affect the cells’ viability or their ability to differentiate and migrate toward the target tissue. In addition, the contrast agent must either incorporate into the cell cytoplasm (intracellular cell labeling) or bind to the cell surface (extracellular cell labeling).</Para>
                <Section3 ID="Sec3_14">
                  <Heading>Intracellular Cell Labeling</Heading>
                  <Para>Superparamagnetic iron oxide nanoparticles (SPIO) were introduced as contrast agents for cell labeling shortly after the use of gadolinium-chelates (<CitationRef CitationID="CR10_14">10</CitationRef>). They are currently the preferred choice mainly because of the following properties (a) they provide the most change in signal per unit (size) of metal, in particular on T2*-weighted images; (b) they are composed of iron, which is biocompatible and can thus be recycled by cells using normal biochemical pathways for iron metabolism; (c) their surface coating allows the chemical linkage of functional groups and ligands; and (d) they can be easily detected by light and electron microscopy.</Para>
                  <Para>SPIO require stabilization in order to prevent aggregation. Most commonly this is accomplished by a surface coating of dextran. Dextran-coated iron oxide nanoparticles (DCSPIO) include the products Feridex<Superscript>®</Superscript> and Endorem<Superscript>®</Superscript> (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig1">1</InternalRef>
                    <Emphasis Type="Bold">a</Emphasis>), the ultra-small SPIO Combidex<Superscript>®</Superscript> and Sinerem<Superscript>®</Superscript>, monocrystalline SPIO, and cross-linked SPIO. Endorem is available in the form of an aqueous colloid. Iron crystal size varies over a range of 4.3–5.6nm; the whole particle size is 120–150nm (<CitationRef CitationID="CR12_14">12</CitationRef>). The particles are characterized by high relaxivities of the same order of magnitude as those of monocrystal iron-oxide nanoparticle-based contrast agents; however, the relaxivity related to iron content is lower, because iron does not create monocrystals and thus the superparamagnetic moment is lower. Nevertheless, the contrast agent Endorem can be easily incorporated by endocytosis, and all the cells survive and further divide in vitro. In experiments conducted in our laboratory, cell cultures of human or rat mesenchymal stem cells (hMSCs, rMSCs), rat olfactory ensheathing cells (rOECs), or human chondrocytes were incubated 2–3 days in media containing Endorem. Additionally, feeder-free D3 mouse embryonic stem cells (ESCs) transfected with the pEGFP-C1 vector were labeled with Endorem (112.4mg/ml) for three passages (<CitationRef CitationID="CR13_14">13</CitationRef>). Nanoparticles were detected by staining for iron (Prussian blue; <Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig1">1</InternalRef>
                    <Emphasis Type="Bold">b</Emphasis>). Transmission electron microscopy confirmed the presence of iron-oxide particles inside the cells, observed as membrane-bound clusters within the cell cytoplasm (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig1">1</InternalRef>
                    <Emphasis Type="Bold">c</Emphasis>). On the day that nanoparticles were withdrawn, the efficiency of MSC labeling (i.e., how many cells out of the total number of analyzed cells were labeled) was 50–70%. The average amount of iron present in rat MSCs determined by spectrophotometry after mineralization of iron-labeled cell suspensions was 17pg/cell.<Figure Category="Standard" Float="Yes" ID="Fig1">
                      <Caption Language="En">
                        <CaptionNumber>Fig. 1.</CaptionNumber>
                        <CaptionContent>
                          <SimplePara>Construction of iron-oxide nanoparticles and MSC labeling with iron-oxide nanoparticles. (<Emphasis Type="Bold">a</Emphasis>) The contrast agent Endorem consists of a superparamagnetic Fe<Subscript>3</Subscript>O<Subscript>4</Subscript> core that is coated by a dextran shell. (<Emphasis Type="Bold">b</Emphasis>) Cells in culture labeled with BrdU (dark nuclei), containing superparamagnetic nanoparticles (<Emphasis Type="Italic">black dots</Emphasis>). (<Emphasis Type="Bold">c</Emphasis>) Transmission electron microphotograph of a cluster of iron nanoparticles surrounded by a cell membrane (modified from (<CitationRef CitationID="CR11_14">11</CitationRef>)).</SimplePara>
                        </CaptionContent>
                      </Caption>
                      <MediaObject>
                        <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_14_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                      </MediaObject>
                    </Figure>
                  </Para>
                  <Para>Another labeling approach is based on combining a commercially available dextran-coated SPIO, such as Feridex<Superscript>®</Superscript> or Sinerem<Superscript>®</Superscript>, and a commercially available transfection agent, for example Superfect<Superscript>™</Superscript>, poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine, Lipofectamin, or Fugene<Superscript>™</Superscript>. Transfection agents effectively transport nanoparticles into cells through electrostatic interactions. However, each combination of transfection agent and dextran-coated SPIO nanoparticle has to be carefully titrated and optimized for different cell cultures, since lower concentrations of the transfection agent may result in insufficient cellular uptake, whereas higher concentrations may induce the precipitation of complexes or may be toxic to the cells (<CitationRef CitationID="CR14_14">14</CitationRef>). To overcome these drawbacks, new polycation-bound superparamagnetic iron oxide (PC-SPIO) nanoparticles have beendeveloped (<CitationRef CitationID="CR15_14">15</CitationRef>). PC-SPIO nanoparticles (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig2">2</InternalRef>
                    <Emphasis Type="Bold">a</Emphasis>) combine the advantages of a low concentration of iron in the cell culture media (15.4 μg/ml) with facilitated uptake without the further use of any additives (transfection agents or lipofection) (<CitationRef CitationID="CR17_14">17</CitationRef>). A comparison of standard dextran-coated SPIO and PC-SPIO showed that labeling cells with PC-SPIO nanoparticles was more efficient than labeling with Endorem, i.e., more cells out of the total number of analyzed cells were labeled with PC-SPIO nanoparticles than with Endorem (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig2">2</InternalRef>
                    <Emphasis Type="Bold">b</Emphasis>). The PC-SPIO nanoparticle suspension was used at a much lower iron concentration per milliliter of culture media (15.4 μg/ml) than with Endorem, for which 112.4 μg/ml in the culture media was used, and the cells were incubated with both labels for 3 days. In PC-SPIO-labeled cells, even though the concentration of iron in the culture media was ten times lower (15.4 vs. 112.4 μg/ml culture media), the average amount of iron was 38pg/cell, while in Endorem-labeled cells it was only 17pg/cell. When the concentration of Endorem was decreased to 15.4 μg of iron in 1ml of culture media, viability increased; however, the labeling efficiency fell to 40%.<Figure Category="Standard" Float="Yes" ID="Fig2">
                      <Caption Language="En">
                        <CaptionNumber>Fig. 2.</CaptionNumber>
                        <CaptionContent>
                          <SimplePara>Labeling with polycation-bound superparamagnetic iron oxide nanoparticles (<Emphasis Type="Bold">a</Emphasis>) Schematic illustration of a polycation-bound superparamagnetic iron oxide nanoparticle. (<Emphasis Type="Bold">b</Emphasis>) PC-SPIO-labeled MSCs in culture stained with Prussian blue. (<Emphasis Type="Bold">c–e</Emphasis>) MR images of phantoms formed by a set of test tubes containing a suspension of human MSCs in 0.5-ml gelatin. The cells were unlabeled (control, Co) (<Emphasis Type="Bold">C</Emphasis>) or labeled with Endorem (<Emphasis Type="Bold">d</Emphasis>) or with PC-SPIO nanoparticles (<Emphasis Type="Bold">e</Emphasis>). Phantoms contained 10,000 cells, corresponding to 0.4 cells per image voxel. (<Emphasis Type="Bold">f</Emphasis>) Axial and coronal (<Emphasis Type="Bold">g</Emphasis>) MR images of a rat brain with 1,000 cells labeled with PC-SPIO nanoparticles implanted in the left hemisphere (PC) and 1,000 Endorem-labeled cells implanted in the right hemisphere (En). MR images were taken 3 days after implantation (modified from (<CitationRef CitationID="CR16_14">16</CitationRef>))</SimplePara>
                        </CaptionContent>
                      </Caption>
                      <MediaObject>
                        <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_14_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                      </MediaObject>
                    </Figure>
                  </Para>
                  <Para>MR images of phantoms containing suspensions of PC-SPIO-labeled cells showed a much stronger hypointense signal than did MR images of Endorem-labeled cells (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig2">2</InternalRef>
                    <Emphasis Type="Bold">c–e</Emphasis>). The MR detection limit in vitro was 0.4 cells in the image voxel, while in vivo it was 1,000 cells injected in 5 μl of PBS (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig2">2</InternalRef>
                    <Emphasis Type="Bold">f, g</Emphasis>). Compared to Endorem, the better internalization of PC-SPIO particles into the cells enables their easier MRI detection and tracking in the tissue after transplantation.</Para>
                  <Para>Another example of a suitable surface modification to enhance nanoparticle transport into the cells is coating with <Emphasis Type="SmallCaps">d</Emphasis>-mannose. The cell surface is known to possess receptors for mannose (<CitationRef CitationID="CR18_14">18</CitationRef>), and thus the coated nanoparticles can be easily internalized. New surface-modified iron oxide nanoparticles were developed by the precipitation of Fe(II) and Fe(III) salts with ammonium hydroxide followed by the oxidation of the precipitated magnetite with sodium hypochlorite with the subsequent addition of <Emphasis Type="SmallCaps">d</Emphasis>-mannose solution (<CitationRef CitationID="CR19_14">19</CitationRef>). The efficiency of MSC labeling was about 80%, and cells labeled with <Emphasis Type="SmallCaps">d</Emphasis>-mannose-coated nanoparticles possessed very high relaxivity (12.1s<Superscript>−1</Superscript>/million of cells/ml) when compared to cells labeled with Endorem (1.24s<Superscript>−1</Superscript>/million of cells/ml). The average amount of iron as determined by spectrophotometry after mineralization was 51.7pg of iron per cell. Therefore, <Emphasis Type="SmallCaps">d</Emphasis>-mannose-modified iron oxide nanoparticles are another promising tool for labeling living cells for diagnostic and therapeutic applications in cell-based therapies. Other strategies for developing MR contrast agents that are easy to detect include the utilization of viral protein cages (<CitationRef CitationID="CR20_14">20</CitationRef>) or the use of internalizing monoclonal antibodies (<CitationRef CitationID="CR21_14">21</CitationRef>). Cells in suspension can be labeled using magnetoelectroporation (<CitationRef CitationID="CR22_14">22</CitationRef>).</Para>
                </Section3>
                <Section3 ID="Sec4_14">
                  <Heading>Extracellular Cell Labeling</Heading>
                  <Para>The disadvantage of an intracellular label is that it can affect cell metabolism and subsequently cell viability. In addition, these labels are rather nonspecific; they can be loaded by virtually any cell present in the medium. Particles that do not internalize do not affect cell viability, and keeping cells in culture is not required for cell labeling; however, their attachment to the outer cell membrane is likely to interfere with cell surface interactions, and they may easily detach from the membrane or be transferred to other cells. Long-term follow up is therefore not possible.</Para>
                  <Para>The possibility of labeling only selected cell types would be very useful. Cells labeled and separated by means of immunomagnetic selection would not require in vitro culturing, since the label is attached during separation. This would allow the immediate clinical use of labeled cells. The first experiments using contrast agents bound to an antibody that can specifically bind to a single cell type were performed by Bulte and coworkers (<CitationRef CitationID="CR23_14">23</CitationRef>). They described experiments with human lymphocytes labeled with biotinylated antilymphocyte-directed monoclonal antibodies, to which streptavidin and subsequently biotinylated dextran-magnetite particles were coupled. We tested another type of specific cell labeling using commercially available cell isolation kits for the magnetic separation of CD34<Superscript>+</Superscript> cells (<CitationRef CitationID="CR24_14">24</CitationRef>). CD34<Superscript>+</Superscript> cells are known as hematopoietic progenitor cells. The cells were separated by means of immunomagnetic selection with anti-CD34 antibodies. For sorting, a superparamagnetic iron oxide core coated with a polysaccharide is linked to an antibody that binds to the respective cell type (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig3">3</InternalRef>
                    <Emphasis Type="Bold">a</Emphasis>). The size of the label is comparable to commonly used superparamagnetic MR contrast agents, thus it can provide sufficient contrast on MR images.<Figure Category="Standard" Float="Yes" ID="Fig3">
                      <Caption Language="En">
                        <CaptionNumber>Fig. 3.</CaptionNumber>
                        <CaptionContent>
                          <SimplePara>Scheme of Microbeads and labeling with an extracellular magnetic label. (<Emphasis Type="Bold">a</Emphasis>) Scheme of MicroBeads: A superparamagnetic iron oxide core coated with a polysaccharide is linked to an antibody, which in turn is bound to a cell via an antigen–antibody complex. (<Emphasis Type="Bold">b</Emphasis>) Transmission electron microphotograph of MicroBeads binding to the cell surface. (<Emphasis Type="Bold">c</Emphasis>) A cell implant (in the hemisphere contralateral to the lesion; <Emphasis Type="Italic">arrow</Emphasis>) seen as a hypointense area on MR images 24 h postimplantation (PI). The lesion (<Emphasis Type="Italic">arrowhead</Emphasis>) remains hyperintensive. (<Emphasis Type="Bold">d</Emphasis>) A decreased signal (<Emphasis Type="Italic">arrow</Emphasis>) in the contralateral hemisphere, while a hypointense signal in the lesion (<Emphasis Type="Italic">arrowhead</Emphasis>) is visible 4 weeks after grafting (modified from (<CitationRef CitationID="CR24_14">24</CitationRef>)).</SimplePara>
                        </CaptionContent>
                      </Caption>
                      <MediaObject>
                        <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_14_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                      </MediaObject>
                    </Figure>
                  </Para>
                  <Para>Human CD34<Superscript>+</Superscript> cells from G-CSF mobilized peripheral blood were selected by CliniMACS CD34<Superscript>+</Superscript> Selection Technology (Miltenyi). On electron microscopy images, we determined that the nanoparticles remained bound to the cell surface, and we observed several iron labels attached to the cell surface (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig3">3</InternalRef>
                    <Emphasis Type="Bold">b</Emphasis>). The average iron content per cell, determined by spectrometry, was 0.275 pg. This value is lower by two orders of magnitude than in the case of intracellular cell labels; nevertheless, it still provides reasonable MR contrast (<Emphasis Type="Bold">Fig.</Emphasis>
                    <InternalRef RefID="Fig3">3</InternalRef>
                    <Emphasis Type="Bold">c, d</Emphasis>; (<CitationRef CitationID="CR24_14">24</CitationRef>)).</Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec5_14">
                <Heading>MR Tracking of Implanted Cells in the Injured Brain</Heading>
                <Para>The use of stem cell therapy in stroke has been extensively examined. Endorem-labeled hMSCs, Endorem/BrdU co-labeled rMSCs, or Endorem-labeled eGFP ESCs were grafted into rats (Wistar, males, 2–3 months old) with a cortical photochemical lesion – an experimental model of stroke (<CitationRef CitationID="CR11_14">11</CitationRef>, <CitationRef CitationID="CR13_14">13</CitationRef>, <CitationRef CitationID="CR25_14">25</CitationRef>). The cells were grafted either intracerebrally into the hemisphere contralateral to the lesion or intravenously into the femoral vein. Rats with grafted stem cells were examined weekly for a period of 3–7 weeks posttransplantation using a 4.7 T Bruker spectrometer. Single sagittal, coronal, and transversal images were obtained by a fast gradient echo sequence for localizing subsequent T2-weighted transversal images measured by a standard turbospin echo sequence. The lesion was visible on MR images already 2h after induction as a hyperintense signal and remained visible during the entire measurement period. One week after grafting, a hypointense signal was found in the lesion, which intensifiedduring the second and third weeks regardless of the route of administration (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig4">4</InternalRef>
                  <Emphasis Type="Bold">a, b</Emphasis>); its intensity corresponded to Prussian blue staining, anti-BrdU staining (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig4">4</InternalRef>
                  <Emphasis Type="Bold">c–e</Emphasis>), or GFP labeling (<CitationRef CitationID="CR13_14">13</CitationRef>, <CitationRef CitationID="CR25_14">25</CitationRef>). Human MSCs were also demonstrated in the lesion by PCR detection of human DNA (a human-specific 850bp fragment of α-satellite DNA from human chromosome 17). Similar results were obtained after the injection of ESCs into rats with transient focal cerebral ischemia; the cells migrated toward the lesion (<CitationRef CitationID="CR26_14">26</CitationRef>). Migration of gadolinium/rhodamine-labeled neural progenitors invading the penumbra was observed in a middle cerebral artery occlusion stroke model (<CitationRef CitationID="CR27_14">27</CitationRef>)).<Figure Category="Standard" Float="Yes" ID="Fig4">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 4.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Implantation of MSCs into brains with photochemical lesions. (<Emphasis Type="Bold">a</Emphasis>) MR images of a cortical photochemical lesion and MSCs implanted into the contralateral hemisphere. The cell implant (<Emphasis Type="Italic">black arrow</Emphasis>) in the hemisphere contralateral to the lesion and the lesion itself are seen as hypointensive areas (<Emphasis Type="Italic">black arrowhead</Emphasis>) 15 days after grafting. (<Emphasis Type="Bold">b</Emphasis>) MR images of a cortical photochemical lesion and MSCs injected into the femoral vein. A hypointensive signal (<Emphasis Type="Italic">black arrowhead</Emphasis>) observed 6 weeks after intravenous injection. (<Emphasis Type="Bold">c</Emphasis>) Prussian blue staining of an injection site in the contralateral hemisphere and a photochemical lesion, 4 weeks after grafting. (<Emphasis Type="Bold">d</Emphasis>) Higher magnification microphotograph (inset) anti-BrdU staining showing BrdU-positive MSCs in the lesion and (<Emphasis Type="Bold">e</Emphasis>) Prussian blue-stained MSCs along the left edge of the photochemical lesion (modified from (<CitationRef CitationID="CR25_14">25</CitationRef>)).</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_14_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                    </MediaObject>
                  </Figure>
                </Para>
              </Section2>
              <Section2 ID="Sec6_14">
                <Heading>MR Tracking of Implanted Cells in the Injured Spinal Cord</Heading>
                <Para>Spinal cord injury (SCI) invariably results in the loss of neurons and axonal degeneration at the lesion site, leading to severe functional impairment, paraplegia, or tetraplegia. Currently, there is no effective treatment for SCI. Standard treatment consists of stabilization and a conservative therapy using high doses of methylprednisolone; long-term therapy after SCI focuses on rehabilitation, pain relief, spasticity treatment, and the prevention of complications. The clinically most relevant model of SCI is a balloon-induced compression lesion (<CitationRef CitationID="CR28_14">28</CitationRef>). A 2-French Fogarty catheter is inserted into the dorsal epidural space through a small hole made in the Th10 vertebral arch. A spinal cord lesion is made by balloon inflation (volume 15 μl) at the Th8–Th9 spinal level. Inflation for 5min produces paraplegia and is followed by gradual recovery.</Para>
                <Para>MSCs labeled with Endorem were injected intravenously into the femoral vein 1 week after a transversal spinal cord lesion (<CitationRef CitationID="CR11_14">11</CitationRef>). MR images were taken ex vivo 4 weeks after cell implantation using a standard whole body resonator. MR images of longitudinal spinal cord sections from lesioned nongrafted animals showed the lesion cavity as inhomogeneous tissue with a strong hyperintensive signal (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">a</Emphasis>). Lesions of grafted animals were seen as dark hypointense areas (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">c</Emphasis>), while lesions of animals injected with nanoparticles in PBS were visible as weak hypointense signals (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">e</Emphasis>). Histological evaluation confirmed only a few iron-containing cells in lesioned, control animals (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">b</Emphasis>), strong positivity for iron in grafted animals (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">d</Emphasis>), and a few weakly stained Prussian blue-positive cells in animals injected intravenously with PBS containing nanoparticles (<Emphasis Type="Bold">Fig.</Emphasis>
                  <InternalRef RefID="Fig5">5</InternalRef>
                  <Emphasis Type="Bold">f</Emphasis>). Compared to control rats, in grafted animals the lesion, which was populated by grafted MSCs, was considerably smaller, suggesting a positive effect of the MSCs on lesion repair.<Figure Category="Standard" Float="Yes" ID="Fig5">
                    <Caption Language="En">
                      <CaptionNumber>Fig. 5.</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>MR images and Prussian blue staining of spinal cord compression lesions injected with saline, contrast agent, or nanoparticle-labeled MSCs. (<Emphasis Type="Bold">a</Emphasis>) Longitudinal MR image of a spinal cord lesion 5 weeks after induction. The formation of a lesion cavity is visible as a strong hyperintensive signal (<Emphasis Type="Italic">arrow</Emphasis>). (<Emphasis Type="Bold">b</Emphasis>) A few cells weakly stained for Prussian blue (<Emphasis Type="Italic">dark dots</Emphasis>) can be seen in a spinal cord lesion in an animal without implanted cells. (<Emphasis Type="Bold">c</Emphasis>) Longitudinal MR image 4 weeks after MSC grafting. The lesion with nanoparticle-labeled cells is visible as a dark hypointensive area (<Emphasis Type="Italic">arrow</Emphasis>). (<Emphasis Type="Bold">d</Emphasis>) Dense Prussian blue staining of a lesion populated with nanoparticle-labeled MSCs (<Emphasis Type="Italic">black dots</Emphasis>). (<Emphasis Type="Bold">e</Emphasis>) Longitudinal MR image 4 weeks after the injection of contrast agent. A weak hypointensive signal can be seen in the center of the lesion (<Emphasis Type="Italic">arrow</Emphasis>). (<Emphasis Type="Bold">f</Emphasis>) Weak Prussian blue positivity (<Emphasis Type="Italic">dark dots</Emphasis>) observed in a spinal cord lesion in an animal injected with contrast agent alone (adapted from (<CitationRef CitationID="CR29_14">29</CitationRef>)).</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <MediaObject>
                      <ImageObject Color="Color" FileRef="MediaObjects/978-1-60327-931-4_14_Fig5_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                    </MediaObject>
                  </Figure>
                </Para>
                <Para>The migration of magnetodendrimer-labeled olfactory ensheathing glia (OEG) was also followed in the injured rat spinal cord. Labeled OEG were detectable in vivo by MR imaging for at least 2 months. Labeled OEG migrated in the normal spinal cord as demonstrated by MRI and histological markers. In contrast, OEG showed limited migration in transected spinal cords and were not able to cross the transection gap (<CitationRef CitationID="CR30_14">30</CitationRef>).</Para>
                <Para>So far, all the described studies employed USPIO or SPIO nanoparticles. Experiments with magnetic microspheres were performed in order to label Schwann cell transplants in a demyelinated spinal cord lesion (<CitationRef CitationID="CR31_14">31</CitationRef>). The micron-sized cell label is much more readily detectable by MR and can be distinguished from the surrounding hemorrhage. A potential problem can be the limited uptake of these very large particles. However, the authors demonstrated that transplanted Schwann cells containing up to eight cytoplasmic microspheres were able to myelinate axons in vivo.</Para>
              </Section2>
              <Section2 ID="Sec7_14">
                <Heading>MR Tracking of Implanted Cells in Neurodegenerative Disorders</Heading>
                <Para>Multiple sclerosis is an immune-mediated demyelinating disease of the CNS causing significant disability in young adults. The beneficial effects of cell transplantation have now been shown in experimental autoimmune encephalomyelitis (EAE), an experimental model relevant to human multiple sclerosis (<CitationRef CitationID="CR32_14">32</CitationRef>). The study demonstrated the ability to follow the migration of transplanted PLL-Feridex-labeled neural precursor cells by serial in vivo MR imaging in a mouse model of EAE. The transplanted cells responded to brain inflammation by migrating into the affected white matter tracts. The extent of migration correlated well with the clinical severity of the disease. Magnetic labels can be used for visualizing the multiple inflammatory foci that are found around blood vessels with a disrupted blood–brain barrier. These foci can be visualized by MRI following the intravenous injection of USPIO (<CitationRef CitationID="CR33_14">33</CitationRef>–<CitationRef CitationID="CR35_14">35</CitationRef>), since the magnetic label can be either phagocytized by circulating monocytes or leak through the disrupted blood–brain barrier followed by uptake in resident brain microglia. MRI can also be used to study the contribution of T cells to lesion development (<CitationRef CitationID="CR36_14">36</CitationRef>). The detection of macrophage trafficking in vivo can be generally used to predict the efficacy of anti-inflammatory drugs (<CitationRef CitationID="CR37_14">37</CitationRef>) or other treatments, potentially providing a marker of treatment efficacy, and thus may be used in future clinical applications.</Para>
              </Section2>
              <Section2 ID="Sec8_14">
                <Heading>MR Tracking of Implanted Cells in Brain Tumors</Heading>
                <Para>Recent evidence suggests that stem cells are useful delivery vehicles for brain tumor therapy (<CitationRef CitationID="CR38_14">38</CitationRef>, <CitationRef CitationID="CR39_14">39</CitationRef>). MR tracking was successfully used to demonstrate the incorporation of magnetically labeled bone marrow-derived precursor cells into the tumor vasculature as part of ongoing angiogenesis and neovascularization (<CitationRef CitationID="CR40_14">40</CitationRef>). Glioma-bearing severe combined immunodeficient mice that received SPIO-labeled cells showed hypointense regions within the tumor area. Histology showed iron-labeled cells around the tumor rim, which expressed CD31 and von Willebrand factor, indicating that the transplanted cells had differentiated into endothelial-like cells. In a different study, neural and progenitor cells and MSCs labeled with lipophilic dye-coated superparamagnetic particles were transplanted into rats 1 week after 9L-gliosarcoma cell transplantation. Three-dimensional gradient echo and T2-weighted images revealed the dynamic migration of adult neural progenitor cells and MSCs, detected as a hypointense signal, toward the tumor mass and infiltrating tumor cells. Prussian blue staining showed that areas with grafted cells corresponded to areas with a hypointense signal (<CitationRef CitationID="CR39_14">39</CitationRef>).</Para>
              </Section2>
              <Section2 ID="Sec9_14">
                <Heading>MR Tracking of Implanted Cells in Other Organs</Heading>
                <Para>So far, we have described the use of MR imaging in the CNS. However, several successful applications for MR tracking can be found in other organs, such as heart, liver, kidney, and pancreatic islets. Iron fluorophore particles were used for labeling swine MSCs. Labeled MSCs were injected percutaneously into normal and freshly infarcted swine myocardium. Fluorophore particles provided sufficient MRI contrast for the detection of transplanted cells in the beating heart on a conventional cardiac MR scanner (<CitationRef CitationID="CR41_14">41</CitationRef>). MSCs are potentially important vectors for cell and gene therapy in the liver or kidneys. MSCs labeled with SPIO and a transfection agent were injected into the renal artery trunk or portal vein to visualize SPIO-labeled MSCs within the kidney and liver parenchyma. However, the follow-up was limited to 7 or 12 days, therefore the fate of the cells and the SPIO label over the long term is not known (<CitationRef CitationID="CR42_14">42</CitationRef>).</Para>
                <Para>The contrast agent Resovist (a SPIO-type nanoparticle) was used as a marker of isolated pancreatic islets for MRI. Following transplantation into the liver of a rat, the labeled pancreatic islets could be easily detected as hypointense regions in the liver on T2*-weighted MR images for up to 22 weeks following transplantation. In addition, this method can be used for monitoring islet rejection in allogenic transplantations due to a decrease in the intensity of the hypointense regions during rejection (<CitationRef CitationID="CR43_14">43</CitationRef>, <CitationRef CitationID="CR44_14">44</CitationRef>).</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec10_14">
              <Heading>Materials</Heading>
              <Section2 ID="Sec11_14">
                <Heading>Cell Culturing</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Dulbecco’s Modified Eagle’s Medium (DMEM) – high glucose (4.5g/l) with <Emphasis Type="SmallCaps">l</Emphasis>-Glutamin (PAA, Pasching, Austria) supplemented with 10% fetal bovine serum (FBS, PAA, Pasching, Austria) and with 0.2% primocin (Amaxa, Gaithersburg, MD, USA). Other antibiotics can be used instead of primocin: 100units/ml penicillin and 0.1 mg/ml streptomycin or gentamicin (50 μl/ml).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Phosphate-buffered saline (PBS) pH 7.2.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Solution of trypsin (0.5%) and ethylenediamine tetraacetic acid (EDTA) (0.2 g/l) from Gibco/Invitrogen (Carlsbad, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Solution of paraformaldehyde (4% in phosphate buffer).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Cell culture plasticware: centrifuge tubes, pipettes, Petri dishes (Technoplastic Products (TPP), Trasadingen, Switzerland), and tissue culture flasks (NUNC, Roskilde, Denmark).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Syringes (10 ml, Chirana, Slovak Republic), needles (18G, Becton Dickinson, Heidelberg, Germany).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec12_14">
                <Heading>Cell Labeling</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Adherent cell culture, 40–50% confluent.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Solution of SPIO nanoparticles (Endorem, Guerbet Roissy, France). Stock solution contains 11.24 mg of iron per 1ml of Endorem<Superscript>®</Superscript>.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec13_14">
                <Heading>Prussian Blue Staining</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Hydrochloric acid (0.5% HCl).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>One gram of potassium ferrocyanide (K<Subscript>4</Subscript>[Fe(CN)<Subscript>6</Subscript>]·3H<Subscript>2</Subscript>O; Sigma, St. Louis, USA) is diluted in 100 ml of 0.5% HCl 70% Ethyl Alcohol (EtOH).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Aluminum Sulfate (5% Al<Subscript>2</Subscript> (SO<Subscript>4</Subscript>)<Subscript>3</Subscript>; Sigma, St. Louis, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Nuclear fast red (Sigma, St. Louis, USA) diluted in 5% aluminum sulfate.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec14_14">
                <Heading>In Vitro MR Tracking</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Set of Eppendorf tubes 1.6 ml (CPL Company, San Diego, CA, USA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Cell suspension (2 million cells) labeled with SPIO nanoparticles and fixed in 4% paraformaldehyde.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Cell suspension (2 million cells) unlabeled and fixed in 4% paraformaldehyde (serves as control).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Gelatin (Sigma, St. Louis, USA)</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec15_14">
                <Heading>Cell Implantation and In Vivo MR Tracking</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Suspension of cells labeled with SPIO.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Animal with experimental model of injury or disorder. Since this protocol deals with MR tracking in living recipients, describing the induction of different models of injury is beyond the scope of this protocol.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>MR equipment. The procedure may differ depending on the type (hole dimension, field strength, RF coil used, etc.) of the MRI imager. Procedures and listed sequence parameters are suitable for a standard horizontal bore imager 4.7 T.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec16_14">
              <Heading>Methods</Heading>
              <Para>MR tracking serves for studying how certain lesions target cell migration, at what speed the cells migrate, and for how long they persist in the target organ. High contrast effects on MR images are easily detected within an experimental time frame of about 1–2 h per animal, which is ideal for short and repetitive in vivo MRI. However, there are some disadvantages related to MR tracking in a living organism. The disadvantages include dilution of the contrast agent during cell division and a lack of information about cell viability or function. In addition, in lesioned tissue, hemorrhage products give rise to Prussian blue-positive deposits that are difficult to distinguish from iron-containing nanoparticles <Emphasis Type="BoldItalic">(45</Emphasis>). The hemorrhage degradation products may also be partially localized to macrophages because macrophages constitute the major cellular pathway for the redistribution of iron in mammals. Furthermore, hemorrhage contributes to T2-weighted hypointensity, thus interfering with the detection of labeled cells and complicating the interpretation of MR images. Therefore, it is important to determine whether cell labels remain colocalized with cell transplants, especially under pathological conditions.</Para>
              <Para>With proper attention to the limitations described above, labeling cells with superparamagnetic agents would enable us to deliver the cells and immediately verify whether the cells have populated the target organ. Moreover, it will allow us to follow the migration of such cells when transplanted into humans, establish the optimal number of transplanted cells, define therapeutic windows and monitor cell growth and possible side effects, e.g., malignancies.</Para>
              <Para>The described protocols are prepared for the isolation, expansion, and labeling of rat mesenchymal stem cells and their tracking in rat brain. However, these protocols can be modified to label different adherent cells with SPIO nanoparticles that can be kept in culture for 48–72 h. Similarly, other organs can be imaged as well.</Para>
              <Section2 ID="Sec17_14">
                <Heading>Cell Culturing</Heading>
                <Para>
                  <Emphasis Type="Italic">Isolation and expansion of rat mesenchymal stem cells</Emphasis>. Rat bone marrow mesenchymal stem cells (rMSCs) are obtained from the tibia and femur of 4-week-old rats. The ends of the bones are cut and the marrow is extruded with Dulbecco’s Modified Eagle Medium (DMEM) by using a needle and a syringe. Marrow cells are plated in a 75-cm<Superscript>2</Superscript> tissue culture flask (TPP) in DMEM containing 10% fetal bovine serum (FBS) and 0.2% Primocin (Amaxa). After 24 h, the nonadherent cells are removed by replacing the medium. The medium is replaced every 2–3 days as the cells grow to confluence. The cells are lifted by incubation with 0.5% trypsin (Gibco/Invitrogen). The first passage after plating is usually taken as P0. Cells can be expanded up to passage 5 (P5) though the efficiency of cell labeling decreases with the number of passages.</Para>
              </Section2>
              <Section2 ID="Sec18_14">
                <Heading>Cell Labeling</Heading>
                <Para>A SPIO nanoparticle suspension (10 μl per 1ml of culture medium corresponding to a final concentration of 112.4 μg of iron per 1ml of culture medium) is added to a culture of rat MSCs or any adherent cells (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Note</Emphasis>
                  <InternalRef RefID="Sec22_14">1</InternalRef>). After 72h the contrast agent is washed out, and the cells are harvested and used for either in vitro MR tracking or transplanted into animal models of disease or injury.</Para>
              </Section2>
              <Section2 ID="Sec19_14">
                <Heading>In Vitro MR Tracking</Heading>
                <Para>To verify whether the cells are properly labeled, cell phantoms should be prepared and measured by MRI in vitro.
<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>
                          <Emphasis Type="Italic">Preparation of phantoms containing suspensions of labeled cells</Emphasis>. To avoid deposition of the cells at the bottom of the test vials, the cells should be suspended in 4% gelatin. From a fixed cell suspension containing 2 million SPIO-labeled cells, several 1mL samples can be prepared containing 100,000–1,000,000 cells/mL each. This range of concentrations ensures roughly 1–10 cells in one image voxel at a standard image geometry setting. Fixed cell suspensions in PBS containing the desired number of cells are placed into an Eppendorf tube in half of the final volume (i.e., 0.5 mL). Warm 8% gelatin (0.5 ml) is poured into the tube, mixed with the cells and quickly cooled on ice (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec22_14">2</InternalRef>). The same procedure should be repeated with the unlabeled cells that serve as a control.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>
                          <Emphasis Type="Italic">Magnetic resonance imaging of cell phantoms</Emphasis>. For in vitro measurements we use standard sequences that are used for in vivo measurements, i.e., a T2-weighted turbospin echo sequence with the following parameters: TR = 2,000ms, effective echo time TE = 42.5ms, turbo factor = 4, number of acquisitions AC = 16, matrix 256 × 256, and slice thickness 0.5–1mm. The field of view is chosen according to the size of the samples. For T2*-weighted images, a gradient echo sequence with the same geometry can be used (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec22_14">3</InternalRef>). Parameters of the sequence are TR = 80ms, TE = 5ms, and AC = 32.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec20_14">
                <Heading>In Vivo MRI</Heading>
                <Para>Superparamagnetic particles have a substantial impact on both T2 and T2* relaxation times. Therefore, both T2 (spin echo, turbospin echo) and T2*-weighted (gradient echo) sequences can be used. An implant with superparamagnetic particles will manifest itself as a hypointense area. Although T2*-weighted gradient echo is more sensitive to the presence of superparamagnetic particles, we strongly prefer a T2-weighted turbospin echo sequence, as it provides better anatomical images. The procedure may differ depending on the type (hole dimension, field strength, RF coil used, etc.) of MRI imager. The procedures and listed sequence parameters are suitable for a standard horizontal bore imager 4.7 T.
<OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>
                          <Emphasis Type="Italic">Animal preparation</Emphasis>. The animal should be anesthetized throughout the entire measurement. Simple MRI is relatively short, therefore intubation of the animal is not necessary and passive inhalation of the anesthetic is sufficient for maintaining anesthesia. However, both passive and active (intubated and connected to an air pump) inhalation of a suitable anesthetic can be used. The anesthetized animal is placed and fixed into a heated holder dedicated for MR measurements. An airflow of 200–300 ml/min is maintained through a mouthpiece. The concentration of the inhalation anesthetic should be 1–2% depending on the breathing frequency of the animal. The breathing frequency is maintained at approximately one breath per second. Breathing is monitored throughout the entire experiment. A dedicated surface head coil is placed and fixed over the rat’s head. (A suitable surface coil is better than whole body resonators because of its higher sensitivity.)</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>
                          <Emphasis Type="Italic">Magnetic resonance imaging</Emphasis>. The holder with the animal is placed into the magnet bore. The RF coil must be connected and tuned. An automated procedure for shimming, setting of transmitter power, frequency, and receiver gain should be sufficient for MR imaging; however, if necessary, finely tuning may be done manually. Low resolution images are obtained in three orthogonal planes using a fast low angle gradient echo (FLASH) sequence (flip angle 30°, repetition time TR = 100ms, effective echo time TE = 5ms, matrix 128 × 128, slice thickness 3mm). The animal is repositioned if necessary. These images are used for positioning high resolution T2-weighted images. A sufficient number of slices to cover the entire volume of interest must be measured. Parameters of the sequence are TR = 2,000 ms, effective echo time TE = 42.5ms, turbo factor = 4, number of acquisitions AC = 16, field of view FOV = 3.5 cm, matrix 256 × 256, slice thickness 0.5–1mm, and slice separation 1mm. If the slice thickness is less than 1mm, it is advisable to measure two sets of interleaved images to avoid saturation of neighboring slices during the measurement. This measurement can be supplemented by a T2*-weighted gradient echo sequence with the same geometry; however, the procedure will be more time consuming. Parameters of the sequence are TR = 80ms, TE = 5ms, and AC = 32.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec21_14">
                <Heading>Staining for Iron</Heading>
                <Para>Fixed cells in culture wells or tissue slices are rinsed in distilled water, washed in alcohol (70%) for 2min, and twice rinsed in distilled water. Potassium ferrocyanide (K<Subscript>4</Subscript>[Fe(CN)<Subscript>6</Subscript>]·3H<Subscript>2</Subscript>O) is applied for 30min to produce ferric ferrocyanide (Prussian blue). Cell nuclei are counterstained with nuclear fast red, or hematoxylin can be used (see Note 4).</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec22_14">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Cell labeling</Emphasis>. The concentration of iron can be decreased down to 15 μg of iron/ml of culture media. This positively influences cell viability; however, the labeling efficiency is lower (40–60%, depending on cell type and number of passage). Other SPIO nanoparticles, such as PCIO- or <Emphasis Type="SmallCaps">d</Emphasis>-Mannose coated, can be used in lower concentrations (15 μg of iron/ml of culture media) without adversely affecting viability or labeling efficiency. The presence of nanoparticles in the cell culture medium can be decreased to 48h.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">Preparation of phantoms</Emphasis>: Tubes with cells suspended in gelatin can be vortexed before cooling so the cells are spread evenly.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>
                        <Emphasis Type="Italic">MRI of phantoms</Emphasis>: Cell samples should be imaged at room temperature, otherwise the gelatin partially melts and the samples become inhomogeneous.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>We strongly recommend to simultaneously use another marker for detecting transplanted cells in histological slices. Particularly under pathological conditions, false Prussian blue positivity can result from deposits of iron in hemorrhages or in iron containing proteins (hemosiderin).</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_14.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgments</Heading>
              <SimplePara>This work was supported by grants from the Academy of Sciences of the Czech Republic AV0Z50390703, KAN201110651, the Ministry of Education, Youth and Sports of the Czech Republic 1M0021620803, LC554, the National Grant Agency of the Czech Republic GACR 309/06/1594, the grant agency of the Ministry of Health NR8339-3, and the EC – FP6 project DiMI: LSHB-CT-2005–512146.</SimplePara>
            </Acknowledgments>
            <Bibliography ID="Bib1_14">
              <Heading>References</Heading>
              <Citation ID="CR1_14">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JG</Initials>
                    <FamilyName>Emsley</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BD</Initials>
                    <FamilyName>Mitchell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Kempermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JD</Initials>
                    <FamilyName>Macklis</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells</ArticleTitle>
                  <JournalTitle>Prog Neurobiol</JournalTitle>
                  <VolumeID>75</VolumeID>
                  <FirstPage>321</FirstPage>
                  <LastPage>341</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15913880</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.pneurobio.2005.04.002</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXltVentLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Emsley JG, Mitchell BD, Kempermann G, Macklis JD (2005). Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. <Emphasis Type="Italic">Prog Neurobiol</Emphasis> 75:321–341.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_14">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Fairless</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Barnett</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Olfactory ensheathing cells: their role in central nervous system repair</ArticleTitle>
                  <JournalTitle>Int J Biochem Cell Biol</JournalTitle>
                  <VolumeID>37</VolumeID>
                  <FirstPage>693</FirstPage>
                  <LastPage>699</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15694828</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.biocel.2004.10.010</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVKis7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fairless R, Barnett SC (2005). Olfactory ensheathing cells: their role in central nervous system repair. <Emphasis Type="Italic">Int J Biochem Cell Biol</Emphasis> 37:693–699.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_14">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RD</Initials>
                    <FamilyName>McKay</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Stem cell biology and neurodegenerative disease</ArticleTitle>
                  <JournalTitle>Philos Trans R Soc Lond B Biol Sci</JournalTitle>
                  <VolumeID>359</VolumeID>
                  <FirstPage>851</FirstPage>
                  <LastPage>856</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15293812</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1098/rstb.2004.1472</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXls1Gntr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>McKay RD (2004). Stem cell biology and neurodegenerative disease. <Emphasis Type="Italic">Philos Trans R Soc Lond B Biol Sci</Emphasis> 359:851–856.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_14">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MB</Initials>
                    <FamilyName>Newman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CD</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CV</Initials>
                    <FamilyName>Borlongan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Emerich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PR</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Transplantation of human umbilical cord blood cells in the repair of CNS diseases</ArticleTitle>
                  <JournalTitle>Expert Opin Biol Ther</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>121</FirstPage>
                  <LastPage>130</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14998772</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/14712598.4.2.121</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Newman MB, Davis CD, Borlongan CV, Emerich D, Sanberg PR (2004). Transplantation of human umbilical cord blood cells in the repair of CNS diseases. <Emphasis Type="Italic">Expert Opin Biol Ther</Emphasis> 4:121–130.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_14">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HC</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>YS</Initials>
                    <FamilyName>Shim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Ha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SH</Initials>
                    <FamilyName>Yoon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SR</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BH</Initials>
                    <FamilyName>Choi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HS</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor</ArticleTitle>
                  <JournalTitle>Tissue Eng</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>913</FirstPage>
                  <LastPage>922</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15998231</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/ten.2005.11.913</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXlsl2jtb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Park HC, Shim YS, Ha Y, Yoon SH, Park SR, Choi BH, Park HS (2005). Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. <Emphasis Type="Italic">Tissue Eng</Emphasis> 11:913–922.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_14">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Pluchino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Zanotti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Deleidi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Martino</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Neural stem cells and their use as therapeutic tool in neurological disorders</ArticleTitle>
                  <JournalTitle>Brain Res Brain Res Rev</JournalTitle>
                  <VolumeID>48</VolumeID>
                  <FirstPage>211</FirstPage>
                  <LastPage>219</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15850660</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.brainresrev.2004.12.011</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjs1Cmurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pluchino S, Zanotti L, Deleidi M, Martino G (2005). Neural stem cells and their use as therapeutic tool in neurological disorders. <Emphasis Type="Italic">Brain Res Brain Res Rev</Emphasis> 48:211–219.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_14">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Roitberg</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Transplantation for stroke</ArticleTitle>
                  <JournalTitle>Neurol Res</JournalTitle>
                  <VolumeID>26</VolumeID>
                  <FirstPage>256</FirstPage>
                  <LastPage>264</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15142317</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1179/016164104225014076</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Roitberg B (2004). Transplantation for stroke. <Emphasis Type="Italic">Neurol Res</Emphasis> 26:256–264.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_14">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Uccelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Zappia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Benvenuto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Frassoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Mancardi</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection</ArticleTitle>
                  <JournalTitle>Expert Opin Biol Ther</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>17</FirstPage>
                  <LastPage>22</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16370911</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1517/14712598.6.1.17</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtlCms7%2FI</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Uccelli A, Zappia E, Benvenuto F, Frassoni F, Mancardi G (2006). Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection. <Emphasis Type="Italic">Expert Opin Biol Ther</Emphasis> 6:17–22.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_14">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Zhao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SP</Initials>
                    <FamilyName>Fancy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Magy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Urwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Stem cells, progenitors and myelin repair</ArticleTitle>
                  <JournalTitle>J Anat</JournalTitle>
                  <VolumeID>207</VolumeID>
                  <FirstPage>251</FirstPage>
                  <LastPage>258</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16185249</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1469-7580.2005.00456.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtFSnsbzN</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhao C, Fancy SP, Magy L, Urwin JE, Franklin RJ (2005). Stem cells, progenitors and myelin repair. <Emphasis Type="Italic">J Anat</Emphasis> 207:251–258.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_14">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MH</Initials>
                    <FamilyName>Mendonca Dias</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PC</Initials>
                    <FamilyName>Lauterbur</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>3</VolumeID>
                  <FirstPage>328</FirstPage>
                  <LastPage>330</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3713497</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.1910030218</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaL283ivF2hsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mendonca Dias MH, Lauterbur PC (1986) Ferromagnetic particles as contrast agents for magnetic resonance imaging of liver and spleen. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 3:328–330.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_14">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sykova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelova</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord</ArticleTitle>
                  <JournalTitle>Ann N Y Acad Sci</JournalTitle>
                  <VolumeID>1049</VolumeID>
                  <FirstPage>146</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15965114</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1196/annals.1334.014</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sykova E, Jendelova P (2005). Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. <Emphasis Type="Italic">Ann N Y Acad Sci</Emphasis> 1049:146–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_14">
                <CitationNumber>12.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Bonnemain</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <BookTitle>Superparamagnetic and blood pool agents. Spotlight on Clinical MRI. V.L.C.</BookTitle>
                  <PublisherName>Maffliers</PublisherName>
                  <PublisherLocation>France</PublisherLocation>
                  <FirstPage>75</FirstPage>
                  <LastPage>88</LastPage>
                  <BibComments>pp.</BibComments>
                </BibBook>
                <BibUnstructured>Bonnemain A (1996). Superparamagnetic and blood pool agents. Spotlight on Clinical MRI. V.L.C., Maffliers, France, pp. 75–88.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_14">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Herynek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Urdzikova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Glogarová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kroupová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Bryja</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Andersson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Burian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hájek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sykova</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">MR tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <FirstPage>232</FirstPage>
                  <LastPage>243</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15048921</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.20041</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jendelová P, Herynek V, Urdzikova L, Glogarová K, Kroupová J, Bryja V, Andersson B, Burian M, Hájek M, Sykova E (2004). MR tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. <Emphasis Type="Italic">J Neurosci Res</Emphasis> 76:232–243.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Kalish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Arbab</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Lewis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HA</Initials>
                    <FamilyName>Zywicke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LH</Initials>
                    <FamilyName>Bryant</FamilyName>
                    <Suffix>Jr</Suffix>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>275</FirstPage>
                  <LastPage>282</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12876703</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.10556</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmslOqsLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW, Bryant LH, Jr., Frank JA (2003). Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 50:275–282.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_14">
                <CitationNumber>15.</CitationNumber>
                <BibUnstructured>Horák, D., Syková, E., Babic, M., Jendelová, P., and Hájek, M. (2006). Superparamagnetic Iron Oxide Nanoparticles with Modified Surface and Their Use as Probes for Stem Cell Labeling, PV 1006-120, Czech Republic.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_14">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sykova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelova</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">In vivo tracking of stem cells in brain and spinal cord injury</ArticleTitle>
                  <JournalTitle>Prog Brain Res</JournalTitle>
                  <VolumeID>161</VolumeID>
                  <FirstPage>367</FirstPage>
                  <LastPage>83</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17618991</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0079-6123(06)61026-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXhtFyqt7bJ</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sykova E, Jendelova P (2007). In vivo tracking of stem cells in brain and spinal cord injury. <Emphasis Type="Italic">Prog Brain Res</Emphasis> 161:367–83</BibUnstructured>
              </Citation>
              <Citation ID="CR17_14">
                <CitationNumber>17.</CitationNumber>
                <BibUnstructured>Babic M, Horak D, Trchova M, Jendelova P, Glogarova K, Lesny P, Herynek V, Hajek M, Sykova E (2008). Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 19:740–50.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_14">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zhu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X</Initials>
                    <FamilyName>Bu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Cushion</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TB</Initials>
                    <FamilyName>Kinane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Avraham</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Koziel</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages</ArticleTitle>
                  <JournalTitle>Mol Biol Cell</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>824</FirstPage>
                  <LastPage>834</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15574879</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1091/mbc.E04-06-0463</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVGitbc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang J, Zhu J, Bu X, Cushion M, Kinane TB, Avraham H, Koziel H (2005). Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. <Emphasis Type="Italic">Mol Biol Cell</Emphasis> 16:824–834.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_14">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Horak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Babic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Herynek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Trchova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Pientka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Pollert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hajek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sykova</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">D-mannose-modified iron oxide nanoparticles for stem cell labeling</ArticleTitle>
                  <JournalTitle>Bioconjugate Chem</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>635</FirstPage>
                  <LastPage>44</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/bc060186c</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXjt1Wis78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Horak D, Babic M, Jendelova P, Herynek V, Trchova M, Pientka Z, Pollert E, Hajek M, Sykova E (2007). D-mannose-modified iron oxide nanoparticles for stem cell labeling. <Emphasis Type="Italic">Bioconjugate Chem</Emphasis> 18(3):635–44.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_14">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Allen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Liepold</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Basu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HA</Initials>
                    <FamilyName>Zywicke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Young</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Douglas</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>807</FirstPage>
                  <LastPage>812</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16155869</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.20614</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtFKktL3P</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Allen M, Bulte JW, Liepold L, Basu G, Zywicke HA, Frank JA, Young M, Douglas T (2005). Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 54:807–812.</BibUnstructured>
              </Citation>
              <Citation ID="CR21_14">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RA</Initials>
                    <FamilyName>Brooks</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BM</Initials>
                    <FamilyName>Moskowitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LHJ</Initials>
                    <FamilyName>Bryant</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Relaxometry and magnetometry of the MR contrast agent MION-46L</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>42</VolumeID>
                  <FirstPage>379</FirstPage>
                  <LastPage>384</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10440963</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1522-2594(199908)42:2&lt;379::AID-MRM20&gt;3.0.CO;2-L</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1MzntVekug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bulte JW, Brooks RA, Moskowitz BM, Bryant LHJ, Frank JA (1999). Relaxometry and magnetometry of the MR contrast agent MION-46L. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 42:379–384.</BibUnstructured>
              </Citation>
              <Citation ID="CR22_14">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Walczak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Kedziorek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AA</Initials>
                    <FamilyName>Gilad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Lin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Instant MR labeling of stem cells using magnetoelectroporation</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>54</VolumeID>
                  <FirstPage>769</FirstPage>
                  <LastPage>774</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16161115</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.20701</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2MrisFWqtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Walczak P, Kedziorek DA, Gilad AA, Lin S, Bulte JW (2005). Instant MR labeling of stem cells using magnetoelectroporation. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 54:769–774.</BibUnstructured>
              </Citation>
              <Citation ID="CR23_14">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Hoekstra</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Kamman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RL</Initials>
                    <FamilyName>Magin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Webb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RW</Initials>
                    <FamilyName>Briggs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KG</Initials>
                    <FamilyName>Go</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Hulstaert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Miltenyi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TH</Initials>
                    <FamilyName>The</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>25</VolumeID>
                  <FirstPage>148</FirstPage>
                  <LastPage>157</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1375703</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.1910250115</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK383nvVWqsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH, et al (1992). Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 25:148–157.</BibUnstructured>
              </Citation>
              <Citation ID="CR24_14">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Herynek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Urdzíková</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Glogarová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rahmatová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Fales</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Andersson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Procházka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Zame ník</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Eckschlager</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Kobylka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hájek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Syková</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">MR tracking of human CD34+progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain</ArticleTitle>
                  <JournalTitle>Cell Transplant.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>173</FirstPage>
                  <LastPage>182</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15929552</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3727/000000005783983124</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jendelová P, Herynek V, Urdzíková L, Glogarová K, Rahmatová S, Fales I, Andersson B, Procházka P, Zame ník J, Eckschlager T, Kobylka P, Hájek M, Syková E (2005). MR tracking of human CD34+progenitor cells separated by means of immunomagnetic selection and transplanted into injured rat brain. <Emphasis Type="Italic">Cell Transplant.</Emphasis> 14:173–182.</BibUnstructured>
              </Citation>
              <Citation ID="CR25_14">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Herynek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>De Croos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Glogarová</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Andersson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hájek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Syková</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>767</FirstPage>
                  <LastPage>776</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14523963</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.10585</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jendelová P, Herynek V, De Croos J, Glogarová K, Andersson B, Hájek M, Syková E (2003). Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 50:767–776.</BibUnstructured>
              </Citation>
              <Citation ID="CR26_14">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hoehn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Kustermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Blunk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Wiedermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Trapp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Focking</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>Arnold</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hescheler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BK</Initials>
                    <FamilyName>Fleischmann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Buhrle</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat.</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>100</VolumeID>
                  <FirstPage>1073</FirstPage>
                  <LastPage>1078</LastPage>
<Occurrence Type="DOI">
<Handle>10.1073/pnas.242435499</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T, Focking M, Arnold H, Hescheler J, Fleischmann BK, Buhrle C (2002). Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. <Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 100:1073–1078.</BibUnstructured>
              </Citation>
              <Citation ID="CR27_14">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Modo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Mellodew</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Cash</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Fraser</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TJ</Initials>
                    <FamilyName>Meade</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Price</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SC</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study</ArticleTitle>
                  <JournalTitle>Neuroimage</JournalTitle>
                  <VolumeID>21</VolumeID>
                  <FirstPage>311</FirstPage>
                  <LastPage>317</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14741669</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuroimage.2003.08.030</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Modo M, Mellodew K, Cash D, Fraser SE, Meade TJ, Price J, Williams SC (2004). Mapping transplanted stem cell migration after a stroke: a serial, in vivo magnetic resonance imaging study. <Emphasis Type="Italic">Neuroimage</Emphasis> 21:311–317.</BibUnstructured>
              </Citation>
              <Citation ID="CR28_14">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Vanicky</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Urdzikova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Saganova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Cizkova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Galik</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat</ArticleTitle>
                  <JournalTitle>J Neurotrauma</JournalTitle>
                  <VolumeID>18</VolumeID>
                  <FirstPage>1399</FirstPage>
                  <LastPage>1407</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11780869</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/08977150152725687</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD38%2FlsFegug%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vanicky I, Urdzikova L, Saganova K, Cizkova D, Galik J (2001). A simple and reproducible model of spinal cord injury induced by epidural balloon inflation in the rat. <Emphasis Type="Italic">J Neurotrauma</Emphasis> 18:1399–1407.</BibUnstructured>
              </Citation>
              <Citation ID="CR29_14">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Urdzikova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Jendelova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Glogarova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Burian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hajek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Sykova</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Transplantation of bone marrow stem cells as well as mobilization by granulocyte – colony stimulating factor promote recovery after spinal cord injury in rat</ArticleTitle>
                  <JournalTitle>J Neurotrauma</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>1379</FirstPage>
                  <LastPage>1391</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16958589</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/neu.2006.23.1379</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Urdzikova L, Jendelova P, Glogarova K, Burian M, Hajek M, Sykova E (2006). Transplantation of bone marrow stem cells as well as mobilization by granulocyte – colony stimulating factor promote recovery after spinal cord injury in rat. <Emphasis Type="Italic">J Neurotrauma</Emphasis> 23:1379–1391.</BibUnstructured>
              </Citation>
              <Citation ID="CR30_14">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IH</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Schweinhardt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Douglas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Trifunovski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Hofstetter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Olson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Spenger</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>187</VolumeID>
                  <FirstPage>509</FirstPage>
                  <LastPage>516</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15144877</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.expneurol.2004.02.007</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lee IH, Bulte JW, Schweinhardt P, Douglas T, Trifunovski A, Hofstetter C, Olson L, Spenger C (2004). In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord. <Emphasis Type="Italic">Exp Neurol</Emphasis> 187:509–516.</BibUnstructured>
              </Citation>
              <Citation ID="CR31_14">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Dunning</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MI</Initials>
                    <FamilyName>Kettunen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Ffrench Constant</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Franklin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KM</Initials>
                    <FamilyName>Brindle</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Magnetic resonance imaging of functional Schwann cell transplants labelled with magnetic microspheres</ArticleTitle>
                  <JournalTitle>Neuroimage</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>172</FirstPage>
                  <LastPage>180</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16442816</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuroimage.2005.11.050</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dunning MD, Kettunen MI, Ffrench Constant C, Franklin RJ, Brindle KM (2006). Magnetic resonance imaging of functional Schwann cell transplants labelled with magnetic microspheres. <Emphasis Type="Italic">Neuroimage</Emphasis> 31:172–180.</BibUnstructured>
              </Citation>
              <Citation ID="CR32_14">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Ben-Hur</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>van Heeswijk</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Einstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Aharonowiz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Xue</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EE</Initials>
                    <FamilyName>Frost</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Mori</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BE</Initials>
                    <FamilyName>Reubinoff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <Year>2007</Year>
                  <ArticleTitle Language="En">Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>57</VolumeID>
                  <FirstPage>164</FirstPage>
                  <LastPage>171</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17191231</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.21116</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ben-Hur T, van Heeswijk RB, Einstein O, Aharonowiz M, Xue R, Frost EE, Mori S, Reubinoff BE, Bulte JW (2007). Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 57:164–171.</BibUnstructured>
              </Citation>
              <Citation ID="CR33_14">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Dousset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Ballarino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Delalande</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Coussemacq</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Canioni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KG</Initials>
                    <FamilyName>Petry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Caille</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis</ArticleTitle>
                  <JournalTitle>AJNR Am J Neuroradiol</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>223</FirstPage>
                  <LastPage>227</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10094342</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M7pt1Wmtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dousset V, Ballarino L, Delalande C, Coussemacq M, Canioni P, Petry KG, Caille JM (1999). Comparison of ultrasmall particles of iron oxide (USPIO)-enhanced T2-weighted, conventional T2-weighted, and gadolinium-enhanced T1-weighted MR images in rats with experimental autoimmune encephalomyelitis. <Emphasis Type="Italic">AJNR Am J Neuroradiol</Emphasis> 20:223–227.</BibUnstructured>
              </Citation>
              <Citation ID="CR34_14">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Dousset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Delalande</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Ballarino</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Quesson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Seilhan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Coussemacq</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Thiaudiere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Brochet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Canioni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Caille</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>329</FirstPage>
                  <LastPage>333</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10080281</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/(SICI)1522-2594(199902)41:2&lt;329::AID-MRM17&gt;3.0.CO;2-Z</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M7nvVeltA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dousset V, Delalande C, Ballarino L, Quesson B, Seilhan D, Coussemacq M, Thiaudiere E, Brochet B, Canioni P, Caille JM (1999). In vivo macrophage activity imaging in the central nervous system detected by magnetic resonance. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 41:329–333.</BibUnstructured>
              </Citation>
              <Citation ID="CR35_14">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rausch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Hiest</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Baumann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Cannet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rudin</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>50</VolumeID>
                  <FirstPage>309</FirstPage>
                  <LastPage>314</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12876707</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.10541</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3szksVaruw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rausch M, Hiestand P, Baumann D, Cannet C, Rudin M (2003). MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 50:309–314.</BibUnstructured>
              </Citation>
              <Citation ID="CR36_14">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Shukaliak-Quandt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EK</Initials>
                    <FamilyName>Jordan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Arbab</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H</Initials>
                    <FamilyName>McFarl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis</ArticleTitle>
                  <JournalTitle>Ann Neurol</JournalTitle>
                  <VolumeID>55</VolumeID>
                  <FirstPage>654</FirstPage>
                  <LastPage>659</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15122705</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/ana.20066</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA (2004). Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. <Emphasis Type="Italic">Ann Neurol</Emphasis> 55:654–659.</BibUnstructured>
              </Citation>
              <Citation ID="CR37_14">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rausch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Hiest</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Foster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DR</Initials>
                    <FamilyName>Baumann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Cannet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rudin</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging</ArticleTitle>
                  <JournalTitle>J Magn Reson Imaging</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>16</FirstPage>
                  <LastPage>24</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15221804</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jmri.20057</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rausch M, Hiestand P, Foster CA, Baumann DR, Cannet C, Rudin M (2004). Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. <Emphasis Type="Italic">J Magn Reson Imaging</Emphasis> 20:16–24.</BibUnstructured>
              </Citation>
              <Citation ID="CR38_14">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Nakamizo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Marini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Amano</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Khan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Studeny</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Gumin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Hentschel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Vecil</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Dembinski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Andreeff</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FF</Initials>
                    <FamilyName>Lang</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas</ArticleTitle>
                  <JournalTitle>Cancer Res</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>3307</FirstPage>
                  <LastPage>3318</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15833864</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXjt1yrsro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF (2005). Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. <Emphasis Type="Italic">Cancer Res</Emphasis> 65:3307–3318.</BibUnstructured>
              </Citation>
              <Citation ID="CR39_14">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Q</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ding</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Zhang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AM</Initials>
                    <FamilyName>Robin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Katakowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor</ArticleTitle>
                  <JournalTitle>Neuroimage</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>281</FirstPage>
                  <LastPage>287</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15325375</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.neuroimage.2004.05.019</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkslOjtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zhang Z, Jiang Q, Jiang F, Ding G, Zhang R, Wang L, Zhang L, Robin AM, Katakowski M, Chopp M (2004). In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. <Emphasis Type="Italic">Neuroimage</Emphasis> 23:281–287.</BibUnstructured>
              </Citation>
              <Citation ID="CR40_14">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Glod</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AS</Initials>
                    <FamilyName>Arbab</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Noel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Ashari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HA</Initials>
                    <FamilyName>Fine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Frank</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>420</FirstPage>
                  <LastPage>425</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15331444</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2004-06-2222</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXis1KhsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, Frank JA (2005). Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. <Emphasis Type="Italic">Blood</Emphasis> 105:420–425.</BibUnstructured>
              </Citation>
              <Citation ID="CR41_14">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Hill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Dick</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VK</Initials>
                    <FamilyName>Raman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Thompson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ZX</Initials>
                    <FamilyName>Yu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KA</Initials>
                    <FamilyName>Hinds</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BS</Initials>
                    <FamilyName>Pessanha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Guttman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TR</Initials>
                    <FamilyName>Varney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BJ</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CE</Initials>
                    <FamilyName>Dunbar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>ER</Initials>
                    <FamilyName>McVeigh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RJ</Initials>
                    <FamilyName>Lederman</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells</ArticleTitle>
                  <JournalTitle>Circulation</JournalTitle>
                  <VolumeID>108</VolumeID>
                  <FirstPage>1009</FirstPage>
                  <LastPage>1014</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12912822</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.CIR.0000084537.66419.7A</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hill JM, Dick AJ, Raman VK, Thompson RB, Yu ZX, Hinds KA, Pessanha BS, Guttman MA, Varney TR, Martin BJ, Dunbar CE, McVeigh ER, Lederman RJ (2003). Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells. <Emphasis Type="Italic">Circulation</Emphasis> 108:1009–1014.</BibUnstructured>
              </Citation>
              <Citation ID="CR42_14">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Bos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Delmas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Desmouliere</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Solanilla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O</Initials>
                    <FamilyName>Hauger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Grosset</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I</Initials>
                    <FamilyName>Dubus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Ivanovic</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Rosenbaum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Charbord</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Combe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JW</Initials>
                    <FamilyName>Bulte</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CT</Initials>
                    <FamilyName>Moonen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Ripoche</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Grenier</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver</ArticleTitle>
                  <JournalTitle>Radiology</JournalTitle>
                  <VolumeID>233</VolumeID>
                  <FirstPage>781</FirstPage>
                  <LastPage>789</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15486216</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1148/radiol.2333031714</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, Dubus I, Ivanovic Z, Rosenbaum J, Charbord P, Combe C, Bulte JW, Moonen CT, Ripoche J, Grenier N (2004). In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. <Emphasis Type="Italic">Radiology</Emphasis> 233:781–789.</BibUnstructured>
              </Citation>
              <Citation ID="CR43_14">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Jirak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kriz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Herynek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Andersson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Girman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Burian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Saudek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hajek</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">MRI of transplanted pancreatic islets</ArticleTitle>
                  <JournalTitle>Magn Reson Med</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>1228</FirstPage>
                  <LastPage>1233</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15562474</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/mrm.20282</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jirak D, Kriz J, Herynek V, Andersson B, Girman P, Burian M, Saudek F, Hajek M (2004). MRI of transplanted pancreatic islets. <Emphasis Type="Italic">Magn Reson Med</Emphasis> 52:1228–1233.</BibUnstructured>
              </Citation>
              <Citation ID="CR44_14">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Kriz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Jirak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P</Initials>
                    <FamilyName>Girman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Berkova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Zacharovova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Honsova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lodererova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Hajek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Saudek</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Magnetic resonance imaging of pancreatic islets in tolerance and rejection</ArticleTitle>
                  <JournalTitle>Transplantation</JournalTitle>
                  <VolumeID>80</VolumeID>
                  <FirstPage>1596</FirstPage>
                  <LastPage>1603</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16371931</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/01.tp.0000183959.73681.b9</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kriz J, Jirak D, Girman P, Berkova Z, Zacharovova K, Honsova E, Lodererova A, Hajek M, Saudek F (2005). Magnetic resonance imaging of pancreatic islets in tolerance and rejection. <Emphasis Type="Italic">Transplantation</Emphasis> 80:1596–1603.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>